CLASS II Drug recall · Reported 25 Mar 2015 · FDA Enforcement Report

Colistimethate for Injection USP, 150 mg per vial recalled

Heritage Pharmaceuticals is recalling Colistimethate for Injection USP, 150 mg per vial, distributed nationwide in the US. The recall was initiated on 25 Feb 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # VCOA002; Exp. 09/14, VCOA003; Exp. 10/14, VCOA004; Exp. 10/14 VCOA005; Exp. 01/15, VCOA006; Exp 03/15, VCOA007; Exp 09/15, VCOA008; Exp. 12/15, VCOA009; Exp. 02/16, VCOA010; Exp. 10/16 VCOA011; Exp. 10/16
NDC23155-193
UPC0323155193312

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0415-2015
FDA event ID
70592
Recalling firm
Heritage Pharmaceuticals, Eatontown, NJ
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Classification
Class II
Status
Terminated
Recall initiated
25 Feb 2015
FDA classified
17 Mar 2015
Reported
25 Mar 2015
Type
Voluntary: Firm initiated
Customers notified by
Press Release
Reason category
Sterility

Timeline

25 Feb 2015Recall initiated by company
17 Mar 2015Classified by FDA+20 days
25 Mar 2015Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Colistimethate for Injection USP, 150 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc. NDC 23155-193-31

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is Colistimethate for Injection USP, 150 mg per vial recalled?

Yes. Heritage Pharmaceuticals recalled Colistimethate for Injection USP, 150 mg per vial on 25 Feb 2015. The recall is Class II and its status is Terminated. Recall number D-0415-2015.

Why was it recalled?

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

Which lots are affected?

Lot # VCOA002; Exp. 09/14, VCOA003; Exp. 10/14, VCOA004; Exp. 10/14 VCOA005; Exp. 01/15, VCOA006; Exp 03/15, VCOA007; Exp 09/15, VCOA008; Exp. 12/15, VCOA009; Exp. 02/16, VCOA010; Exp. 10/16 VCOA011; Exp. 10/16

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Heritage Pharmaceuticals

All 23